Balance Sheet Data
Alpine Immune Sciences, Inc. (ALPN)
$10.53
+0.29 (+2.83%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 52.30 | 40.52 | 105.58 | 162.30 | 237.64 | 2,160.45 | 6,279.74 | 18,253.27 | 53,056.58 | 154,219.03 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 0.24 | 0.69 | 0.39 | 25.32 | 0.39 | 32.60 | 94.76 | 275.42 | 800.57 | 2,327.02 |
| Account Receivables (%) | ||||||||||
| Inventories | - | - | - | - | - | - | - | - | - | - |
| Inventories (%) | ||||||||||
| Accounts Payable | 1.72 | 1.54 | 0.58 | 3.35 | 4.29 | 64.12 | 186.37 | 541.72 | 1,574.60 | 4,576.88 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -0.50 | -0.82 | -0.80 | -0.12 | -0.41 | -22.35 | -64.96 | -188.80 | -548.80 | -1,595.18 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.